Vimarsana
Biggest News Aggregation in the World

Gil Bolotin News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Gil Bolotin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Gil Bolotin Today - Breaking & Trending Today

Sploot Veterinary Care Receives Investment From L Catterton - Vimarsana News

Sploot Veterinary Care Receives Investment From L Catterton

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Greenwich's L Catterton invests in Sploot Veterinary Care platform - Vimarsana News

Greenwich's L Catterton invests in Sploot Veterinary Care platform

L Catterton, the Greenwich-based investment firm, announced that it has made a strategic investment in Sploot Veterinary Care, a technology-driven veterinary care platform designed to provide an elevated experience to pets, pet parents, and veterinary professionals.

L Catterton Makes Strategic Investment in Sploot Veterinary Care - Vimarsana News

L Catterton Makes Strategic Investment in Sploot Veterinary Care

/PRNewswire/ -- L Catterton, a leading global consumer-focused investment firm, today announced that it has made a strategic investment in Sploot Veterinary...

Three veterinary chains take space at edge of downtown, LoHi - Vimarsana News

Three veterinary chains take space at edge of downtown, LoHi

One of them is poised to be the first retail tenant to open at the base of the 35-story Confluence apartment building.

Vascular Graft Solutions Wins FDA approval to Market the VIOLA™ Clampless Proximal Anastomosis System for CABG - Vimarsana News

Vascular Graft Solutions Wins FDA approval to Market the VIOLA™ Clampless Proximal Anastomosis System for CABG

Vascular Graft Solutions Wins FDA approval to Market the VIOLA™ Clampless Proximal Anastomosis System for CABG USA - English Share this article Share this article TEL AVIV, Israel, March 1, 2021 /PRNewswire/ -- Vascular Grafts Solutions (VGS) Ltd. announced today receipt of marketing clearance from the Food and Drug Administration (FDA) for the VIOLA™, a new device for clampless proximal anastomosis in coronary artery bypass grafting (CABG). VIOLA™, now approved for sales in the US Neurocognitive dysfunction remains the most devastating perioperative complication of CABG and frequently...